Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies [Phase 1]
Phase 1 pilot study evaluating haploidentical natural killer cell infusions for poor-prognosis non-AML hematologic malignancies has complete…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)
The completed trial conducted by Dana-Farber Cancer Institute evaluated SNP-based genetic markers for predicting oral mucositis risk in pati…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease [Phase 1]
Phase 1 clinical trial evaluating infusion of genetically modified T cells in post-transplant patients with relapsed disease has completed. …
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating the combination of paclitaxel and estramustine in relapsed or refractory Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS research · 2013-07-10Clinical Trial Update: Dual Time Point PET in Lymphoma
This entry reports an ongoing clinical trial evaluating dual time point PET imaging in patients with Hodgkin lymphoma and Non-Hodgkin lympho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
A Phase 2 study evaluating SyB L-0501 in combination with Rituximab for relapsed/refractory diffuse large B-cell lymphoma has completed, wit…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating the use of combination chemotherapy followed by peripheral stem cell transplantation in older patients with refra…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 study evaluating chemotherapy plus radiation therapy followed by peripheral stem cell transplantation for Non-Hodgkin lymphoma; the …
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas
Clinical trial update noting the completed status of a study evaluating whole-body MRI for staging Hodgkin lymphoma and Non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 dose-escalation study of TAK-901 in subjects with advanced hematologic malignancies; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma [Phase 4]
Phase 4 clinical trial update evaluating the pharmacokinetics and clinical response of doxorubicin in patients with Non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Evaluating the Utility of the Apoptosis Imaging Biomarker 18F]ML10 in Patients With Non-Hodgkin's Lymphoma(NHL) [Phase 1]
A Phase 1 clinical trial evaluating the apoptosis imaging biomarker 18F]ML10 in patients with non-Hodgkin's lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 trial evaluating combination chemotherapy for aggressive Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]
A completed Phase 1 study evaluating thalidomide in patients with asymptomatic indolent non-Hodgkin lymphoma or chronic lymphocytic leukemia…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating combination chemotherapy in pediatric patients with stage III/IV Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer [Phase 2]
Phase 2 clinical trial update examining the combination of phenylbutyrate and azacitidine in patients with acute myeloid leukemia, myelodysp…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 trial evaluating adding monoclonal antibody therapy to chemotherapy in older patients with Non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss [Phase 3]
Phase 3 trial evaluating zoledronic acid for chemotherapy-induced bone loss completed; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy in patients with acute lymphoblastic leukemia or non-Hodgkin lymphoma. The stud…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma [Phase 2]
Phase 2 trial of arsenic trioxide in relapsed or refractory non-Hodgkin lymphoma has completed, with study results reported.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial update evaluating interferon alfa-2b in patients with advanced low-grade Non-Hodgkin lymphoma; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer [Phase 1]
This clinical trial update reports the Phase 1 safety and tolerability results of PCI-24781 in cancer patients. The study, sponsored by Phar…
-
FDA approval · 2013-06-17FDA Approved: CYCLOPHOSPHAMIDE — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for cyclophosphamide from Civica, Inc. under ANDA 040745.
-
CLINICAL_TRIALS withdrawal · 2013-06-06Clinical Trial Update: Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating obatoclax mesylate in combination with rituximab and bendamustine hydrochloride for relapsed or refrac…
-
FDA approval · 2013-06-04FDA Approved: MOZOBIL — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for MOZOBIL (plerixafor) submitted by Sanofi-Aventis U.S. LLC.